---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-24-012079"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2024-07-08T23:59:59+00:00"
generated_at: "2026-05-31T23:05:53.235957+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve conversion of Series A Preferred Stock for up to $25M financing

## Summary
- Proposal approved with 5,356,845 votes for, 79,371 against, 3,043 abstentions; no broker non-votes.
- Conversion relates to Securities Purchase Agreement dated May 8, 2024, for total purchase price up to $25,000,000.
- Approval required under Nasdaq Rule 5635 for issuance exceeding certain share thresholds.
- Special meeting held July 8, 2024; record date May 29, 2024.

## SEC filing metadata
- accession: 0001214659-24-012079
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2024-07-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465924012079/0001214659-24-012079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465924012079/o782458k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-24-012079
- JSON: https://secwatch.observer/filing/0001214659-24-012079.json
- Plain text: https://secwatch.observer/filing/0001214659-24-012079.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.